Bringing an orphan drug to market By / On July 1, 2022 / At 12:22 pm / In Chemical world 49 Views Eiger picks CordenPharma to make lonafarnib, the first drug for progeria, an ultrarare premature aging disease Post navigation Prev PostSetting up to deliver a therapy for ALS Next PostFrom a shark to a possible Parkinson’s drug You May Also Like Chemical chainmail constructed from interlocked coordination polymers On January 27, 2023 | In Chemical world Dispute over mass crustacean deaths at Teesside as pyridine and pathogen both blamed On January 27, 2023 | In Chemical world Deuterium drugs attract investment On January 26, 2023 | In Chemical world